Literature DB >> 8017747

The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results.

S N Goodman1, J A Berlin.   

Abstract

Although there is a growing understanding of the importance of statistical power considerations when designing studies and of the value of confidence intervals when interpreting data, confusion exists about the reverse arrangement: the role of confidence intervals in study design and of power in interpretation. Confidence intervals should play an important role when setting sample size, and power should play no role once the data have been collected, but exactly the opposite procedure is widely practiced. In this commentary, we present the reasons why the calculation of power after a study is over is inappropriate and how confidence intervals can be used during both study design and study interpretation.

Mesh:

Year:  1994        PMID: 8017747     DOI: 10.7326/0003-4819-121-3-199408010-00008

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  147 in total

1.  Subject-by-formulation interaction in bioequivalence: conceptual and statistical issues. FDA Population/Individual Bioequivalence Working Group. Food and Drug Administration.

Authors:  W W Hauck; T Hyslop; M L Chen; R Patnaik; R L Williams
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Economics notes: cost effectiveness calculations and sample size.

Authors:  D J Torgerson; M K Campbell
Journal:  BMJ       Date:  2000-09-16

3.  Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.

Authors:  Seo Young Kim; Sebastian Schneeweiss; Jun Liu; Daniel H Solomon
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

4.  Long-term cognition, achievement, socioemotional, and behavioral development of healthy late-preterm infants.

Authors:  Matthew J Gurka; Jennifer LoCasale-Crouch; James A Blackman
Journal:  Arch Pediatr Adolesc Med       Date:  2010-06

Review 5.  Determination of the clinical importance of study results.

Authors:  Malcolm Man-Son-Hing; Andreas Laupacis; Keith O'Rourke; Frank J Molnar; Jeffery Mahon; Karen B Y Chan; George Wells
Journal:  J Gen Intern Med       Date:  2002-06       Impact factor: 5.128

6.  How to spot bias and other potential problems in randomised controlled trials.

Authors:  S C Lewis; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

7.  A power calculation guide for fMRI studies.

Authors:  Jeanette A Mumford
Journal:  Soc Cogn Affect Neurosci       Date:  2012-05-28       Impact factor: 3.436

8.  The ongoing tyranny of statistical significance testing in biomedical research.

Authors:  Andreas Stang; Charles Poole; Oliver Kuss
Journal:  Eur J Epidemiol       Date:  2010-03-26       Impact factor: 8.082

9.  Randomized Controlled Trial of Imagery Rehearsal for Posttraumatic Nightmares in Combat Veterans.

Authors:  Gerlinde C Harb; Joan M Cook; Andrea J Phelps; Philip R Gehrman; David Forbes; Russell Localio; Ilan Harpaz-Rotem; Ruben C Gur; Richard J Ross
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

10.  Combined rectopexy and sacrocolpopexy is safe for correction of pelvic organ prolapse.

Authors:  Cristina B Geltzeiler; Elisa H Birnbaum; Matthew L Silviera; Matthew G Mutch; Joel Vetter; Paul E Wise; Steven R Hunt; Sean C Glasgow
Journal:  Int J Colorectal Dis       Date:  2018-08-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.